DePuy Attune Revision Knee Introduced Amid Rising Concerns Over Implant Failures

The Johnson & Johnson subsidiary DePuy Synthes is launching a new Attune Revision Knee System, which is designed for use among individuals who need to undergo additional surgery if their previous knee implants fail. The move comes amid increasing concerns about reports of knee replacement complications linked to the design of the DePuy Attune knee system.  

The manufacturer announced the new revision knee system in a press release issued on March 6, which will be introduced at the 2018 American Academy of Orthopaedic Surgeons (AAOD) Annual Meeting in New Orleans, Louisiana.

The DePuy Attune Revision Knee System is designed to address some of the challenges surgeons face when patients require revision surgery, particularly in cases where large bone defects present reconstruction and fixation issues.

While DePuy Synthes indicates that the product is intended to serve the approximately 5% of patients who require knee revision surgery, a growing number of health experts have raised concerns in recent months that the DePuy Attune knee failure rates may be substantially higher.

Last year, in a report published in the Journal of Knee Surgery, researchers noted a spike in DePuy Attune knee tibial loosening and failures, raising concerns about problems at the implant-cement interface.

As of June 2017, the FDA adverse event reporting system already had about 1,400 incidents of early DePuy Attune knee problems, including at least 633 cases where individuals required revision surgery. As a result, several experts suggest that there may be design problems that could result in additional implant failures over the coming months and years.

Over the past year, the company has faced a number of DePuy Attune knee lawsuits filed by individuals who had their implant fail only a few years after joint replacement surgery, alleging that the manufacturer sold a defective and unreasonably dangerous product.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.
A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL.
Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation.